Anti-IL-6 therapy has been met with success in the treatment of rheumatoid arthritis, and mice treated with anti-IL6 and/or anti-IL-6R antibody therapy markedly reduces post-traumatic OA, laying the foundation for its use as a therapy to treat OA [41,42]. This evidence concerns the gene IL6 and rheumatoid arthritis.